Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques

A Randomized Double-Blind Placebo-Controlled Crab Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques in NTU Campus

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02208414

Enrollment

Registered

2014-08-05

Start date

2012-06-30

Completion date

2014-12-31

Last updated

2014-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food Allergies

Keywords

Food Allergies

Brief summary

Purpose of this study is to determine whether NAET procedures are effective in the treatment of crab or shrimp allergy. Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.

Detailed description

Nambudripad allergy elimination techniques (NAET) were developed by Dr. Devi Nambudripad in 1983. Many patients have been relieved of allergy and allergy-related disease by this treatment. Lack of well-controlled clinical study prevents NAET from being accepted as a treatment option in current medical system. The aim of this project is to conduct a double blind-placebo controlled study of applying NAET to treat crab or shrimp allergy. The parameters to be measured are allergic symptom, crab- or shrimp-specific IgE and skin test before and after NAET treatment

Interventions

PROCEDURENAET

NAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Older or equal to 20 years old * History of allergic to crab or shrimp * Positive serum crab- or shrimp-specific IgE

Exclusion criteria

* History of anaphylactic shock * On medication of anti-histamine or steroid * Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Change from Baseline in allergic symptoms at 6 months	before NAET and 6 months after NAET	Symptoms when exposed to crab or shrimp which include symptoms of skin, eye, respiratory tract, gastrointestinal tract, cardiovascular system and others. The participants give score subjectively from 0 to 10 according to the severity of the symptoms.

Secondary

Measure	Time frame	Description
Serum crab- or shrimp-specific IgE	before NAET, 1 month, 3 months and 6 months after NAET	—
Skin test	before NAET, 1 month and 6 months after NAET	Skin test for crab or shrimp extract

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026